Orexo AB (FRA:C5G)
€ 0.885 0.004 (0.45%) Market Cap: 31.52 Mil Enterprise Value: 73.01 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q1 2019 Orexo AB Earnings Call Transcript

May 02, 2019 / 12:00PM GMT
Release Date Price: €6.62 (+2.80%)
Operator

Ladies and gentlemen, welcome to the Orexo AB audio conference -- teleconference Q1 2019 call. Today, I'm pleased to present Nikolaj Sørensen, Chief Executive Officer and Joseph DeFeo, Chief Financial Officer. (Operator Instructions) Speakers, please begin.

Nikolaj SÃ;rensen;publ;President;CEO
Orexo AB

¸ - ()-&

Thank you very much, and welcome to this first quarter call for Orexo in 2019. If I look back on the quarter we have just been through, it has been a very strong start of 2019. Leading a pharmaceutical company, I think the main topic is do you want to show good sales growth and we have shown good sales growth, in particular in Swedish krona, but also in local currency. It's about profitability. We have improved our profitability substantially coming from the U.S. business and even on the corporate level despite having a significant cost for [leading] in this quarter. It's about developing a pipeline. And while we know there's a risk in the pipeline as some projects does not progress exactly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot